ÿþ<HTML><HEAD><TITLE>25º Congresso Brasileiro de Microbiologia </TITLE><link rel=STYLESHEET type=text/css href=css.css></HEAD><BODY aLink=#ff0000 bgColor=#FFFFFF leftMargin=0 link=#000000 text=#000000 topMargin=0 vLink=#000000 marginheight=0 marginwidth=0><table align=center width=700 cellpadding=0 cellspacing=0><tr><td align=left bgcolor=#cccccc valign=top width=550><font face=arial size=2><strong><font face=Verdana, Arial, Helvetica, sans-serif size=3><font size=1>25º Congresso Brasileiro de Microbiologia </font></font></strong><font face=Verdana size=1><b><br></b></font><font face=Verdana, Arial,Helvetica, sans-serif size=1><strong> </strong></font></font></td><td align=right bgcolor=#cccccc valign=top width=150><font face=arial size=2><strong><font face=Verdana, Arial, Helvetica, sans-serif size=1><font size=1>ResumoID:80-1</font></em></font></strong></font></td></tr><tr><td colspan=2><br><br><table align=center width=700><tr><td>Área: <b>Ecologia Microbiana ( Divisão I )</b><p align=justify><strong><P CLASS=MSONORMAL STYLE="MARGIN: 0CM 0CM 0PT; LINE-HEIGHT: 200%; TEXT-ALIGN: JUSTIFY">EFFECT OF ORAL TREATMENT WITH BIFIDOBACTERIUM ANIMALIS VAR. LACTIS IN EXPERIMENTAL INFECTION WITH SALMONELLA TYPHIMURIUM IN GNOTOBIOTIC AND CONVENTIONAL MICE</P></strong></p><p align=justify><b><u>Ariane Katiuscia Santos Martins </u></b> (<i>UFMG</i>); <b>Flaviano dos Santos Martins </b> (<i>UFMG</i>); <b>Danielle Alves Gomes </b> (<i>UFMG</i>); <b>Samir Andrade Deus Elian </b> (<i>UFMG</i>); <b>Angélica Thomaz Vieira </b> (<i>UFMG</i>); <b>Mauro Martins Teixeira </b> (<i>UFMG</i>); <b>Denise Carmona Cara Machado </b> (<i>UFMG</i>); <b>Regina Maria Nardi Drummond </b> (<i>UFMG</i>); <b>Jacques Robert Nicoli </b> (<i>UFMG</i>)<br><br></p><b><font size=2>Resumo</font></b><p align=justify class=tres><font size=2><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: 'Times New Roman','serif'; mso-fareast-language: PT-BR; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-bidi-language: AR-SA">Second the World Health Organization (WHO), probiotic can be defined as a preparation containing live microorganisms that, when administered in sufficient amounts, confers a beneficial effect to the host. Among the microorganisms more frequently utilized as probiotic we could mention the genus <I style="mso-bidi-font-style: normal">Bifidobacterium</I>. The present work had the aim to investigate the oral treatment with two strains of <I style="mso-bidi-font-style: normal">Bifidobacterium</I> <I style="mso-bidi-font-style: normal">animalis </I>var. <I style="mso-bidi-font-style: normal">lactis</I>, in gnotobiotic and conventional mice, challenged with <I style="mso-bidi-font-style: normal">Salmonella</I> <I style="mso-bidi-font-style: normal">enterica</I> sorovar Typhimurium. Utilizing tests of antagonism <I style="mso-bidi-font-style: normal">in vitro</I> was observed that the two strains were able to produce antagonistic substance <I style="mso-bidi-font-style: normal">in vitro</I> against pathogenic microorganisms. In <I style="mso-bidi-font-style: normal">ex vivo</I> antagonism test were produced antagonistic substances only against three of the ten microorganisms tested. In addition the <I style="mso-bidi-font-style: normal">Bifidobacterium</I> strains were able to colonize and maintain in high numbers in the digestive tract of gnotobiotic mice. The two strains had a low intensity translocation (only to Peyer s Patch and mesenteric linfonodes) and didn t cause any histological lesion in none of the organs analyzed of the monoassociated mice. <I style="mso-bidi-font-style: normal">Bifidobacterium animalis</I> var <I style="mso-bidi-font-style: normal">lactis</I> BB-12 e BB-12 free were able to reduce the numbers of <I style="mso-bidi-font-style: normal">Salmonella</I> in the gnotobiotic mice challenged with the pathogen and treated with the probiotics, but only BB-12 free was able to confer a protection in the ileum of animals against the oral challenge with<I style="mso-bidi-font-style: normal"> S.</I> Typhimurium and a decrease in mortality of animals pre-treated with it. Higher levels of sIgA (<I style="mso-bidi-font-style: normal">P</I> &lt; 0.05) and IL-10 (<I style="mso-bidi-font-style: normal">P</I> = 0.055) were observed only in BB-12 free mono-associated mice when compared to germ-free group. We could conclude that, among the parameters analyzed, the strains BB-12 free exhibited the more desirable characteristics to be used as a probiotic.</SPAN></font></p><br><b>Palavras-chave: </b>&nbsp;Probiotics, Bifidobacterium animalis, Salmonella enterica sorovar Typhimurium, translocation, sIgA, IL-10</td></tr></table></tr></td></table></body></html>